Atlas Venture Associates X, LLC's Net Worth
$0
Who is Atlas Venture Associates X, LLC?
Atlas Venture Associates X, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals Holding Co LLC, Generation Bio Co., Replimune Group, Inc., Ikena Oncology, Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., Disc Medicine, Inc., AVROBIO, Inc., and Homology Medicines, Inc..
SEC CIK
Atlas Venture Associates X, LLC's CIK is 0001742765
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Day One Biopharmaceuticals Holding Co LLC (DAWN) Snapshot price: $13.5
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ikena Oncology, Inc. (IKNA) Snapshot price: $1.77
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,809.29% | 4.75M |
—
|
—
| 4.92M |
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Generation Bio Co. (GBIO) Snapshot price: $2.18
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.26% | -81.09K |
$25.40 | -$2,059,519.16 | 608 |
Scheduled
|
Sep 27 - Sep 29
| ||
Form 4
| -62.30% | -135.00K |
$26.02 | -$3,511,992.53 | 81.7K |
Scheduled
|
Sep 22 - Sep 24
| ||
Form 4
| -98.08% | -31.01K |
$25.86 | -$801,618.16 | 608 |
Scheduled
|
Jun 24
| ||
Form 4
| -85.41% | -185.08K |
$25.05 | -$4,635,967.02 | 31.62K |
Scheduled
|
Jun 21 - Jun 23
| ||
Form 4
| -100.00% | -140.68K |
$25.92 | -$3,646,968.15 |
0
|
Scheduled
|
Apr 12 - Apr 14
| ||
Form 4
| -47.46% | -127.09K |
$28.20 | -$3,583,860.22 | 140.68K |
Scheduled
|
Apr 7 - Apr 9
| ||
Form 4
| +387.54% | 10.04M |
—
|
—
| 12.63M |
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Replimune Group, Inc. (REPL) Snapshot price: $10.88
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.45M |
—
|
—
| 4.45M |
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.03% | -353.36K |
$42.20 | -$14,912,376.40 | 5.5M |
Scheduled
|
Mar 11 - Mar 13
| ||
Form 4
| -2.11% | -126.47K |
$30.22 | -$3,821,738.64 | 5.86M |
Scheduled
|
Jan 11 - Jan 12
| ||
Form 4
| -6.00% | -382.24K |
$31.36 | -$11,985,953.69 | 5.98M |
Scheduled
|
Dec 14 - Dec 15
| ||
Form 4
| -3.34% | -220.02K |
$30.01 | -$6,602,952.38 | 6.37M |
Scheduled
|
Nov 2 - Nov 3
| ||
Form 4
| -4.20% | -288.70K |
$30.26 | -$8,735,143.37 | 6.59M |
Scheduled
|
Oct 28 - Nov 1
| ||
Form 4
| -100.00% | -242.13K |
$61.00 | -$14,770,113.00 |
0
|
Aug 11
| |||
Form 4
| -100.00% | -229.35K |
$56.50 | -$12,958,275.00 |
0
|
Mar 12
| |||
Form 4
| +1,104.37% | 8.31M |
—
|
—
| 9.06M |
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||